HomeNewsIndiaGovt initiates consultation process for new science, technology and innovation policy

Govt initiates consultation process for new science, technology and innovation policy

The fifth S&T policy of the country is being formulated at a crucial juncture when India and the world are tackling the COVID-19 pandemic.

June 03, 2020 / 15:13 IST
Story continues below Advertisement
Representative image
Representative image

The government has initiated a consultation process for formulation of a new national Science, Technology and Innovation Policy (STIP 2020), a statement said.

The Office of the Principal Scientific Adviser to the Government of India (Office of PSA) and the Department of Science and Technology (DST) have jointly initiated a decentralised, bottom-up and inclusive process for the formulation of the new policy, it said.

Story continues below Advertisement

The fifth S&T policy of the country is being formulated at a crucial juncture when India and the world are tackling the COVID-19 pandemic.

"As the crisis changes the world, the new policy with its decentralised manner of formation will reorient STI in terms of priorities, sectoral focus, the way research is done, and technologies are developed and deployed for larger socio-economic welfare," the statement issued on Tuesday said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show